山东益康药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
86
NMPA:86
Drug Approvals
Omeprazole and Sodium Bicarbonate for Suspension（Ⅰ）
- Product Name
- 奥美拉唑碳酸氢钠干混悬剂(Ⅰ)
- Approval Number
- 国药准字H20253244
- Approval Date
- Jan 24, 2025
NMPA
Loxoprofen Sodium Oral Solution
- Product Name
- 洛索洛芬钠口服溶液
- Approval Number
- 国药准字H20244131
- Approval Date
- Jun 25, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20247088
- Approval Date
- Apr 29, 2024
NMPA
Isosorbide Mononitrate Tablets
- Product Name
- 单硝酸异山梨酯片
- Approval Number
- 国药准字H20083718
- Approval Date
- Jul 25, 2023
NMPA
Tropisetron Hydrochloride Capsules
- Product Name
- 盐酸托烷司琼胶囊
- Approval Number
- 国药准字H20080600
- Approval Date
- Jun 24, 2023
NMPA
Cefaclor for Suspension
- Product Name
- 头孢克洛干混悬剂
- Approval Number
- 国药准字H20084417
- Approval Date
- May 25, 2023
NMPA
Amoxicillin and Clavulanate Potassium Granules
- Product Name
- 阿莫西林克拉维酸钾颗粒
- Approval Number
- 国药准字H20083802
- Approval Date
- May 25, 2023
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20183057
- Approval Date
- Apr 11, 2023
NMPA
Propacetamol Hydrochloride
- Product Name
- 盐酸丙帕他莫
- Approval Number
- 国药准字H20080029
- Approval Date
- Aug 17, 2022
NMPA
Paracetamol Oral Solution
- Product Name
- 对乙酰氨基酚口服溶液
- Approval Number
- 国药准字H20103611
- Approval Date
- Aug 12, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found